Dr. Melotek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8980 S US Highway 1
Ste 105
Port St. Lucie, FL 34952Phone+1 772-281-3060Fax+1 772-281-3055
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2013 - 2017- University of ChicagoInternship, Internal Medicine, 2012 - 2013
University of Florida College of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2017 - 2026
IL State Medical License 2017 - 2020- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 45 citationsA Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)Christine M. Bestvina, K.B. Pointer, Theodore Karrison, Hania A. Al-Hallaq, Philip C. Hoffman
Journal of Thoracic Oncology. 2021-09-06 - 1 citationsUpdate of Radiation Techniques Using Photons for Anterior Skull Base TumorsCorey C. Foster, Joseph K. Kim, J.M. Melotek, Nancy Y. Lee
Advances in Oto-Rhino-Laryngology. 2020-07-30 - 15 citationsDose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional OutcomesCorey C. Foster, Tanguy Y. Seiwert, Ellen MacCracken, Elizabeth A. Blair, Nishant Agrawal
International Journal of Radiation Oncology, Biology, Physics. 2020-07-15
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Press Mentions
Role of Cetuximab Expands in Head and Neck CancerJune 2nd, 2016
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
